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MICs considered to be in the susceptible range (≤2.0 g/ml) but420 15th ICID Abstracts / International Journa
nd anti-biogrampattern of enterococci species collected in Shahid
ohammadi hospital.
Methods: In this descriptive cross sectional study, performed
etween March 2010 and March 2011, about 4487 various clinical
pecimens of hospitalized patients were investigated for entero-
occi species. The specimens were cultured on Blood agar, EMB
nd Chocolate agar. Suspicious colonies were identiﬁed by Gram
taining, growth in bile salt and NaCl 6.5% media. Antibiogram pat-
erns were determined by Kirby-Bauer method on Mueller-Hinton
edium. Clinical and microbiological data was analyzed by SPSS16
oftware.
Results: A total of 55 (4.47%) species of enterococci was iso-
ated from 1229 positive cultures.Enterococci was mostly (34.5%)
btained from old age (>65y) patients and internal (>50%) wards
specially internal 1 (23.6%). Urinary tract (67.3%) and wounds
10.9%)were the twomajor sitesof infection.Nitrofurantoin (80.6%)
ndvancomycin (75%)weremost effective antibiotics, respectively.
high rate of resistance was observed to cephalosporines (78.6%)
nd Aminoglycosides (67.4%). Mortality rate was 16.3% with ente-
ococcal infections.
Conclusion: In our study the most susceptible antibiotics were
itrofurantoin and vancomycin, which aligns with some other
tudies. Because of high frequency and multi- drug resistance of
nterococci species, continuous monitoring of antimicrobial sus-
eptibility and strict adherent to infection guidelines are essential
o prevent and eliminate enterococci infections.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.580
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Background: One of the most difﬁcult problems in hospitals
s the appearance of an increased number of Pseudomonas antibi-
tic resistant strains. It is characterised by intrinsic and acquired
esistance tomany antibiotic classes causing the treatment of these
nfections difﬁcult.
Methods: In this study we examined antibiotic resistance rates
f clinical isolates of P. aeruginosa recovered in Saint George Gen-
ral Hospital of Chania and Regional Institute of Gastroenterology
Hepatology of Cluj Napoca.
From Greece we investigated a total of 246 strains of P.
eruginosa isolated fromall cultures (urine, blood, trauma, etc) dur-
ng 2009, from all clinics including the ICU and 24 strains isolatedfectious Diseases 16S (2012) e317–e473
in Cluj Napoca from different samples. Strains from Romania were
collected fromnosocomial infections, inanational surveillancepro-
gram and all strains were collected from ICU. The identiﬁcation to
the species level was achieved by standard procedures and by the
automated system Vitek2 Biomerieux. The susceptibility tests of
isolates were performed by disk diffusion method according to the
CLSI criteria and by the Vitek2 system Biomerieux, using a panel of
29 antibiotics.
Results: The results are presented in the table that follows.
Antibiotics % Resistance of
P.aeruginosa In
Greece
% Resistance of
P.aeruginosa In
Romania
TCC ticarcillin/clavulanic acid 36.7% 87.5%
TZP piperacillin/tazobactam 16.7% 87.5%
CAZ ceftazidime 17.9% 91.7%
FEP cefepime 20.7% 91.7%
IPM imipenem 25.7% 79.1%
MEM meropenem 23.5% 79.1%
COL colistin 2.5% 8.33%
CIP ciproﬂoxacin 36.1% 79.2%
AMK amikacin 18% 80%
InGreece, 23of the isolates fromICU,were susceptible to colistin
only (9.3%) and resistant to all antibiotics. In Romania, 15 of the
isolateswere susceptible to colistin only (62.5%) and2 isolateswere
resistant to all antibiotics (8.33%).
Conclusion: In Greece, amikacin and ceftazidime have
remained active against the majority of P.aeruginosa clinical iso-
lates. Results from Romania could reﬂect the implication of some
hospital multi resistant Pseudomonas strains in nosocomial infec-
tions. Carbapenems should be used with caution due to elevated
percentage of resistance against this class of antibiotics. Colistin
is effective against multidrug resistant strains. Antibiotic policy in
combination with infection-control measures are needed to pre-
vent the spread of multidrug resistant and panresistant strains in
the hospital.
http://dx.doi.org/10.1016/j.ijid.2012.05.581
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Background: Glycopeptides have been used widely to treat
methicillin resistant Staphylococcus aureus (MRSA) infections.
Until recently vancomycin resistance among gram-positive bac-
teria had been thought to be uncommon but Glycopeptide
intermediate S. aureus (GISA) and heterogenous GISA (hGISA) have
been reported from various parts of world. Strains of hGISA havecontain a subset of the bacterial population that expresses the
resistance phenotype.This study has been done to evaluate the
current status of glycopeptides intermediate and heterogenoiously
